Table 1 patient characteristics
| Â | clinical event | without clinical event | Â |
|---|---|---|---|
n = 88 | n = 150 | p - value | |
age (in years) | 58 ± 10 | 56 ± 11 | n.s. |
Male (%) | 85 | 84 | n.s. |
risk profile | Â | Â | Â |
hypertension (%) | 59 | 52 | n.s. |
diabetes mellitus | 31 | 11 | <0,001 |
hyperlipidemia (%) | 78 | 78 | n.s. |
hypercholesterinemia (%) | 69 | 70 | n.s. |
hypertriglyceridemia (%) | 29 | 32 | n.s. |
history of smoking or smoking (%) | 69 | 66 | n.s. |
positive family history (%) | 44 | 42 | n.s. |
Anamnese | Â | Â | Â |
history of myokardial infarction (%) | 44 | 51 | n.s. |
history of ACB operation (%) | 10 | 5,4 | n.s. |
history of PTCA (%) | 57 | 61 | n.s. |
Medication | Â | Â | Â |
nitrates (%) | 87 | 80 | n.s. |
calcium channel blockers (%) | 50 | 41 | n.s. |
betablockers (%) | 41 | 46 | n.s. |
ace-inhibitors (%) | 31 | 28 | n.s. |
thrombocytaggregationinhibitors (%) | 73 | 78 | n.s. |
lipid lowering medication (%) | 37 | 45 | n.s. |
insuline (%) | 1,1 | 1,4 | n.s. |
oral andiabetic medication (%) | 10 | 3,4 | p < 0,05 |